First Time Loading...

ESSA Pharma Inc
NASDAQ:EPIX

Watchlist Manager
ESSA Pharma Inc Logo
ESSA Pharma Inc
NASDAQ:EPIX
Watchlist
Price: 5.61 USD 4.28%
Updated: Jul 16, 2024
Have any thoughts about
ESSA Pharma Inc?
Write Note

Relative Value

There is not enough data to reliably calculate the relative value of EPIX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EPIX Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.8
vs History
vs Industry
Median 3Y
-8.1
Median 5Y
-7.8
Industry
24.2
Forward
-6.7
vs History
vs Industry
Median 3Y
-10.6
Median 5Y
-8.4
Industry
22.1
vs History
vs Industry
Median 3Y
-10.6
Median 5Y
-6.9
Industry
21.6
vs History
61
vs Industry
47
Median 3Y
1.6
Median 5Y
2.2
Industry
2.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.6
vs History
vs Industry
8
Median 3Y
-1 427.9
Median 5Y
-1 555.6
Industry
8.8
vs History
vs Industry
28
Median 3Y
-2.7
Median 5Y
-3.3
Industry
4.4
vs History
vs Industry
26
Median 3Y
-2.7
Median 5Y
-3.3
Industry
4.3
Forward
-2.7
vs History
vs Industry
25
Median 3Y
-3.9
Median 5Y
-4.3
Industry
5.3
vs History
vs Industry
22
Median 3Y
-3.9
Median 5Y
-4.3
Industry
3.3
vs History
vs Industry
18
Median 3Y
-67.4
Median 5Y
27.9
Industry
4.6

Multiples Across Competitors

EPIX Competitors Multiples
ESSA Pharma Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
ESSA Pharma Inc
NASDAQ:EPIX
248.9m USD 0 -9 -3.3 -3.3
US
Abbvie Inc
NYSE:ABBV
298B USD 5.5 50 14 21.5
US
Amgen Inc
NASDAQ:AMGN
179.3B USD 6 47.4 19.8 32.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
128.1B USD 12.6 31.9 27 28.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
120.8B USD 9.2 31.2 25.5 28.2
AU
CSL Ltd
ASX:CSL
148.7B AUD 7.1 40.7 24.3 30.2
US
Gilead Sciences Inc
NASDAQ:GILD
89.7B USD 3.3 184.9 9.3 12.2
US
Moderna Inc
NASDAQ:MRNA
47.8B USD 9.2 -8 -8.7 -7.8
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
32.4B USD 16.2 -98 -253.9 -176.7
US
Biogen Inc
NASDAQ:BIIB
32.7B USD 3.4 27.8 14.3 17.8
P/E Multiple
Earnings Growth
CA
ESSA Pharma Inc
NASDAQ:EPIX
Average P/E: 59.1
Negative Multiple: -9
N/A
US
Abbvie Inc
NYSE:ABBV
50
406%
US
Amgen Inc
NASDAQ:AMGN
47.4
75%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.9
50%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
31.2
50%
AU
CSL Ltd
ASX:CSL
40.7
81%
US
Gilead Sciences Inc
NASDAQ:GILD
184.9
70%
US
Moderna Inc
NASDAQ:MRNA
Negative Multiple: -8 N/A
US
Seagen Inc
NASDAQ:SGEN
Negative Multiple: -57.5 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -98 N/A
US
Biogen Inc
NASDAQ:BIIB
27.8
148%
EV/EBITDA Multiple
EBITDA Growth
CA
ESSA Pharma Inc
NASDAQ:EPIX
Average EV/EBITDA: 19.1
Negative Multiple: -3.3
N/A
US
Abbvie Inc
NYSE:ABBV
14
28%
US
Amgen Inc
NASDAQ:AMGN
19.8
58%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27
60%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
25.5
52%
AU
CSL Ltd
ASX:CSL
24.3
53%
US
Gilead Sciences Inc
NASDAQ:GILD
9.3
16%
US
Moderna Inc
NASDAQ:MRNA
Negative Multiple: -8.7 N/A
US
Seagen Inc
NASDAQ:SGEN
Negative Multiple: -61.9 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -253.9 N/A
US
Biogen Inc
NASDAQ:BIIB
14.3
56%
EV/EBIT Multiple
EBIT Growth
CA
ESSA Pharma Inc
NASDAQ:EPIX
Average EV/EBIT: 24.4
Negative Multiple: -3.3
N/A
US
Abbvie Inc
NYSE:ABBV
21.5
88%
US
Amgen Inc
NASDAQ:AMGN
32.6
95%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.2
58%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
28.2
52%
AU
CSL Ltd
ASX:CSL
30.2
68%
US
Gilead Sciences Inc
NASDAQ:GILD
12.2
33%
US
Moderna Inc
NASDAQ:MRNA
Negative Multiple: -7.8 N/A
US
Seagen Inc
NASDAQ:SGEN
Negative Multiple: -55.8 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -176.7 N/A
US
Biogen Inc
NASDAQ:BIIB
17.8
71%

See Also

Discover More